InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Nussbaum Robert L, Directeur Médical. Insider active across 1 company, notably Invitae Corp. In total, 20 disclosures have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €1.5m. Activity tracked since 30 April 2021. The latest transaction was disclosed on 20 December 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations20 total
17,404 shares@ US$0.6480.6% of flowCommon StockSEC:0000950170-23-072402:0
7,086 shares@ US$1.3770.5% of flowCommon StockSEC:0000950170-23-028349:0
26,476 shares@ US$1.19931.6% of flowCommon StockSEC:0000899243-23-013235:0
155,000 shares0Common StockSEC:0000899243-23-010814:0
2,625 shares@ US$1.410.2% of flowCommon StockSEC:0000950170-23-008158:0
54,000 shares0Common StockSEC:0000899243-22-029703:0
7,048 shares@ US$4.55031.8% of flowCommon StockSEC:0000899243-22-029156:0
6,098 shares@ US$3.81011.3% of flowCommon StockSEC:0000899243-22-018871:0
168,511 shares0Common StockSEC:0000899243-22-014563:0
14,705 shares0Common StockSEC:0000899243-22-011321:0
13,269 shares@ US$9.906.8% of flowCommon StockSEC:0000899243-21-044611:0
13,269 shares@ US$9.9013.7% of flowCommon StockSEC:0000899243-21-044611
1,666 shares@ US$1.260.1% of flowCommon StockSEC:0000899243-21-033857:0
1,666 shares@ US$1.260.1% of flowCommon StockSEC:0000899243-21-033857
21,231 shares@ US$25.417227.1% of flowCommon StockSEC:0000899243-21-033561:0
21,231 shares@ US$25.417225.9% of flowCommon StockSEC:0000899243-21-033561
9,910 shares@ US$31.625115.3% of flowCommon StockSEC:0000899243-21-024194:0
9,910 shares@ US$31.625114.6% of flowCommon StockSEC:0000899243-21-024194
44,700 shares0Common StockSEC:0000899243-21-018205:0
44,700 shares0Common StockSEC:0000899243-21-018205
20 of 20 declarations
About Nussbaum Robert L
Robert L. Nussbaum is the Chief Medical Officer at Invitae Corp. He oversees the company's medical and scientific initiatives, focusing on innovation in the field of genetics. His role is crucial for developing new tests and solutions, thereby contributing to Invitae's mission of making genetics accessible to all.
